Healthcare
M&A Advisory
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Verastem. United States. Announced Date 26/01/2012. Closed Date 31/01/2012. Deal value: $55m. Initial public offering. Industry: Verastem is a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients.